Recombinant DNA Technology in Immunology: Advancing Vaccines and Therapeutic Proteins

Introduction

Recombinant DNA (rDNA) technology has revolutionized the field of immunology by enabling the production of vaccines and therapeutic proteins. This technology involves the manipulation of genetic material to create proteins with high specificity and efficacy for medical applications. It has led to groundbreaking advancements in vaccine development and the treatment of various diseases, including autoimmune disorders and genetic deficiencies.

Recombinant DNA vaccines for immunity, therapeutic proteins in immunology, genetic engineering in vaccine development, biotechnology in immune response

What is Recombinant DNA Technology?

Recombinant DNA technology involves combining DNA from different sources to create novel genetic sequences that can be expressed in host cells. These genetically engineered cells can produce proteins used for therapeutic and prophylactic purposes.

Steps in Recombinant DNA Technology:

  1. Isolation of Gene of Interest: The gene encoding the desired protein is identified and extracted.
  2. Insertion into a Vector: The gene is inserted into a plasmid or viral vector.
  3. Transformation into Host Cells: The recombinant vector is introduced into bacterial, yeast, or mammalian cells.
  4. Expression of Recombinant Protein: Host cells produce the desired protein, which is then purified for medical use.
  5. Quality Control and Testing: The protein undergoes rigorous testing to ensure efficacy and safety.

Role of Recombinant DNA Technology in Vaccines

Types of Recombinant Vaccines

  1. Subunit Vaccines: Contain only specific antigenic components of a pathogen, reducing side effects.
    • Example: Hepatitis B vaccine.
  2. DNA Vaccines: Introduce genetically engineered DNA to produce an immune response.
    • Example: Zika virus vaccine candidates.
  3. mRNA Vaccines: Use messenger RNA to instruct cells to produce an immune-stimulating protein.
    • Example: Pfizer-BioNTech and Moderna COVID-19 vaccines.
  4. Recombinant Vector Vaccines: Use a virus as a vector to deliver genetic material for immunity.
    • Example: AstraZeneca and Johnson & Johnson COVID-19 vaccines.

Advantages of Recombinant Vaccines

  • High specificity and purity.
  • Lower risk of causing infection.
  • Scalable and cost-effective production.
  • Stable formulations for long-term storage.

Recombinant DNA Technology in Therapeutic Proteins

Types of Therapeutic Proteins Produced Using rDNA Technology

  1. Hormones:
    • Insulin: Recombinant human insulin (Humulin) is used for diabetes treatment.
    • Growth Hormone: Human Growth Hormone (hGH) for growth disorders.
  2. Cytokines and Immune Modulators:
    • Interferons: Used to treat multiple sclerosis and viral infections.
    • Interleukins: IL-2 for cancer therapy.
  3. Blood Clotting Factors:
    • Factor VIII & IX: Used for hemophilia treatment.
  4. Monoclonal Antibodies (mAbs):
    • Trastuzumab (Herceptin): Used for breast cancer.
    • Rituximab: Used for autoimmune diseases and lymphomas.
    • Bevacizumab (Avastin): Used for colorectal and lung cancer.

Advantages of Recombinant Therapeutic Proteins

  • High purity and potency.
  • Reduced risk of immune rejection.
  • Large-scale production capability.
  • Customization for specific medical needs.

Challenges in Recombinant DNA Technology

  • High Production Costs: Research, development, and regulatory approvals are expensive.
  • Ethical Concerns: Genetic manipulation raises bioethical issues.
  • Viral Contamination Risks: Expression systems may carry risks of viral contamination.
  • Storage and Stability Issues: Some recombinant proteins require specific storage conditions.

Future Prospects

  • Personalized Medicine: Recombinant DNA technology will drive the development of individualized therapies.
  • Next-Generation Vaccines: More effective and stable vaccines will emerge.
  • Synthetic Biology Applications: Engineering synthetic biological systems for improved healthcare solutions.

Relevant Website Links

For more detailed insights into Recombinant DNA Technology in immunology, visit:

Further Reading

Conclusion

Recombinant DNA technology has profoundly impacted immunology, leading to the development of effective vaccines and life-saving therapeutic proteins. As research continues, this technology holds the promise of further advancements in disease prevention and treatment, enhancing global health outcomes.

MCQs on Recombinant DNA Technology in Immunology: Vaccines and Therapeutic Proteins

1. What is the primary purpose of recombinant DNA technology in vaccine production?

A) To enhance natural immunity
B) To produce safer and more effective vaccines
C) To increase the size of the genome
D) To make the body immune to all diseases

✅ Answer: B) To produce safer and more effective vaccines
✔ Explanation: Recombinant DNA technology allows the production of vaccines that contain specific antigens, reducing the risk of adverse effects and increasing safety.

2. Which of the following is a recombinant vaccine?

A) Oral polio vaccine
B) BCG vaccine
C) Hepatitis B vaccine
D) Rabies vaccine

✅ Answer: C) Hepatitis B vaccine
✔ Explanation: The Hepatitis B vaccine is produced using recombinant DNA technology, where the antigenic protein is expressed in yeast cells.

3. What is the key advantage of recombinant vaccines over traditional vaccines?

A) They do not require refrigeration
B) They have fewer side effects and are safer
C) They provide lifelong immunity in a single dose
D) They can cure diseases instead of preventing them

✅ Answer: B) They have fewer side effects and are safer
✔ Explanation: Recombinant vaccines use only specific antigenic proteins rather than whole pathogens, reducing the risk of infection and adverse reactions.

4. Which organism is commonly used to produce recombinant insulin?

A) Saccharomyces cerevisiae
B) Escherichia coli
C) Mycobacterium tuberculosis
D) Plasmodium falciparum

✅ Answer: B) Escherichia coli
✔ Explanation: Recombinant human insulin is produced using genetically engineered Escherichia coli, which expresses the human insulin gene.

5. Which of the following is an example of a subunit vaccine?

A) DTP vaccine
B) Influenza vaccine
C) HPV vaccine
D) Smallpox vaccine

✅ Answer: C) HPV vaccine
✔ Explanation: Subunit vaccines, like the Human Papillomavirus (HPV) vaccine, contain only specific proteins rather than entire pathogens.

6. The first recombinant DNA vaccine developed for human use was for which disease?

A) Polio
B) Hepatitis B
C) Influenza
D) Tuberculosis

✅ Answer: B) Hepatitis B
✔ Explanation: The Hepatitis B vaccine was the first recombinant DNA-based vaccine approved for human use.

7. Which vector is commonly used for the production of recombinant vaccines?

A) Retrovirus
B) Plasmid
C) Bacteriophage
D) Transposon

✅ Answer: B) Plasmid
✔ Explanation: Plasmids are widely used as vectors in recombinant DNA technology to introduce genes coding for vaccine antigens.

8. What is the main function of an adjuvant in vaccines?

A) To boost the immune response
B) To kill bacteria in the vaccine
C) To reduce side effects
D) To enhance genetic modification

✅ Answer: A) To boost the immune response
✔ Explanation: Adjuvants enhance the immune response to an antigen, making vaccines more effective.

9. Which therapeutic protein is produced using recombinant DNA technology for treating diabetes?

A) Insulin
B) Erythropoietin
C) Interferon
D) Hemoglobin

✅ Answer: A) Insulin
✔ Explanation: Recombinant human insulin is produced using genetically modified E. coli or Saccharomyces cerevisiae.

10. Which method is commonly used to insert recombinant DNA into host cells?

A) Polymerase chain reaction (PCR)
B) Gel electrophoresis
C) Gene cloning
D) Transformation

✅ Answer: D) Transformation
✔ Explanation: Transformation involves the introduction of foreign DNA into a host cell, commonly used in recombinant DNA technology.

11. What is the role of restriction enzymes in recombinant DNA technology?

A) To amplify DNA
B) To cut DNA at specific sequences
C) To synthesize new DNA strands
D) To transport DNA into cells

✅ Answer: B) To cut DNA at specific sequences
✔ Explanation: Restriction enzymes recognize specific nucleotide sequences and cut DNA at those sites, allowing the insertion of foreign genes.

12. Recombinant DNA technology helps in producing monoclonal antibodies. These are used for:

A) Treating bacterial infections
B) Diagnosing and treating diseases like cancer
C) Increasing metabolism
D) Cloning animals

✅ Answer: B) Diagnosing and treating diseases like cancer
✔ Explanation: Monoclonal antibodies target specific antigens and are widely used in cancer therapy and disease diagnosis.

13. What type of vaccine is the recombinant COVID-19 vaccine developed by AstraZeneca?

A) Inactivated vaccine
B) Live attenuated vaccine
C) Viral vector vaccine
D) Toxoid vaccine

✅ Answer: C) Viral vector vaccine
✔ Explanation: AstraZeneca’s COVID-19 vaccine uses a recombinant viral vector (adenovirus) to deliver the genetic code for the SARS-CoV-2 spike protein.

14. Which gene-editing tool is widely used for modifying DNA in vaccine production?

A) CRISPR-Cas9
B) DNA polymerase
C) Reverse transcriptase
D) Helicase

✅ Answer: A) CRISPR-Cas9
✔ Explanation: CRISPR-Cas9 is a precise gene-editing tool that allows the modification of DNA sequences for vaccine and therapeutic protein development.

15. Which recombinant protein is used for the treatment of anemia?

A) Insulin
B) Erythropoietin
C) Somatotropin
D) Thrombin

✅ Answer: B) Erythropoietin
✔ Explanation: Recombinant erythropoietin (EPO) stimulates red blood cell production and is used to treat anemia, especially in kidney failure patients.

16. Which of the following is a recombinant therapeutic protein used to dissolve blood clots?

A) Interleukin
B) Tissue Plasminogen Activator (tPA)
C) Growth hormone
D) Hemoglobin

✅ Answer: B) Tissue Plasminogen Activator (tPA)
✔ Explanation: tPA is a recombinant protein used to treat stroke and heart attacks by dissolving blood clots.

17. Why are yeast cells (Saccharomyces cerevisiae) used for producing recombinant vaccines?

A) They produce antibodies
B) They can express complex proteins
C) They are similar to bacteria
D) They cause fewer allergic reactions

✅ Answer: B) They can express complex proteins
✔ Explanation: Yeast cells can efficiently produce large amounts of recombinant proteins, such as the Hepatitis B surface antigen.

18. What is an example of a DNA vaccine?

A) Polio vaccine
B) Pfizer-BioNTech COVID-19 vaccine
C) Tuberculosis vaccine
D) Smallpox vaccine

✅ Answer: B) Pfizer-BioNTech COVID-19 vaccine
✔ Explanation: DNA and mRNA vaccines, like Pfizer-BioNTech’s COVID-19 vaccine, use genetic material to instruct cells to produce an immune response.

19. The recombinant BCG vaccine is being developed for better protection against which disease?

A) Tuberculosis
B) Malaria
C) Typhoid
D) HIV/AIDS

✅ Answer: A) Tuberculosis
✔ Explanation: The recombinant BCG vaccine aims to enhance immunity against tuberculosis by improving antigen presentation.

20. What is the advantage of mRNA vaccines over traditional vaccines?

A) They do not require booster doses
B) They can be developed quickly and are highly effective
C) They use whole virus particles
D) They are stored at room temperature

✅ Answer: B) They can be developed quickly and are highly effective
✔ Explanation: mRNA vaccines, like those for COVID-19, can be produced faster and induce strong immune responses.

21. What is the main characteristic of live attenuated recombinant vaccines?

A) They use inactivated viruses
B) They contain whole, killed bacteria
C) They use a weakened virus expressing a recombinant antigen
D) They use heat-killed pathogens

✅ Answer: C) They use a weakened virus expressing a recombinant antigen
✔ Explanation: These vaccines use genetically modified viruses that express antigens but do not cause disease.

22. Which recombinant cytokine is used in cancer immunotherapy?

A) Interferon-alpha
B) Erythropoietin
C) Insulin
D) Somatotropin

✅ Answer: A) Interferon-alpha
✔ Explanation: Interferon-alpha is used to stimulate immune responses in viral infections and cancer therapy.

23. The HPV vaccine protects against which type of cancer?

A) Lung cancer
B) Cervical cancer
C) Brain cancer
D) Blood cancer

✅ Answer: B) Cervical cancer
✔ Explanation: The recombinant HPV vaccine prevents infections from human papillomavirus strains linked to cervical cancer.

24. What is the role of a recombinant protein in gene therapy?

A) To kill infected cells
B) To replace defective genes
C) To create artificial viruses
D) To destroy antibodies

✅ Answer: B) To replace defective genes
✔ Explanation: Recombinant proteins help correct genetic disorders by delivering functional genes.

25. Which bacteria is commonly used in recombinant DNA technology for therapeutic protein production?

A) Staphylococcus aureus
B) Escherichia coli
C) Clostridium botulinum
D) Pseudomonas aeruginosa

✅ Answer: B) Escherichia coli
✔ Explanation: E. coli is frequently used for producing recombinant proteins like insulin and growth hormones.

26. What does the term “biopharming” refer to?

A) Farming bacteria for genetic modification
B) Producing pharmaceuticals using genetically modified plants or animals
C) Developing antibiotics
D) Cloning humans

✅ Answer: B) Producing pharmaceuticals using genetically modified plants or animals
✔ Explanation: Biopharming involves using genetically engineered plants or animals to produce medicinal proteins.

27. Which of the following is a recombinant clotting factor used for hemophilia treatment?

A) Factor VIII
B) Factor XIII
C) Albumin
D) Hemoglobin

✅ Answer: A) Factor VIII
✔ Explanation: Recombinant Factor VIII is used in treating hemophilia A patients with clotting deficiencies.

28. What is the significance of recombinant Hepatitis B vaccine?

A) It uses inactivated whole viruses
B) It contains the HBsAg protein produced in yeast
C) It uses weakened bacteria
D) It is a DNA-based vaccine

✅ Answer: B) It contains the HBsAg protein produced in yeast
✔ Explanation: The Hepatitis B vaccine contains recombinant surface antigen (HBsAg) produced in Saccharomyces cerevisiae.

29. Which of the following diseases is being targeted by recombinant DNA-based malaria vaccines?

A) Influenza
B) Malaria
C) Tuberculosis
D) Hepatitis A

✅ Answer: B) Malaria
✔ Explanation: Recombinant malaria vaccines are being developed to target Plasmodium species.

30. What is the advantage of recombinant therapeutic proteins over conventional treatments?

A) They are less expensive
B) They are identical to human proteins and reduce immune rejection
C) They eliminate all diseases permanently
D) They do not require storage

✅ Answer: B) They are identical to human proteins and reduce immune rejection
✔ Explanation: Recombinant proteins closely resemble natural human proteins, reducing immune system rejection.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here